AXL and cancer: The receptor tyrosine kinase Axl is implicated in the Snai1-, Snai2-, IL6-, and STAT3-mediated activation of EMT (72, 73) as well as the metastasis promoting AKT/NF-κB and AKT/Snai2 pathways (73, 74) in multiple cancer types.